S. Markaki

1.2k total citations
44 papers, 925 citations indexed

About

S. Markaki is a scholar working on Surgery, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, S. Markaki has authored 44 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Molecular Biology and 9 papers in Obstetrics and Gynecology. Recurrent topics in S. Markaki's work include Sarcoma Diagnosis and Treatment (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Uterine Myomas and Treatments (6 papers). S. Markaki is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Uterine Myomas and Treatments (6 papers). S. Markaki collaborates with scholars based in Greece, United States and United Kingdom. S. Markaki's co-authors include Antonios Keramopoulos, L. Nakopoulou, Ioanna Giannopoulou, G. Vlachos, Meletios Α. Dimopoulos, Lydia Nakopoulou, Eugenia Mylona, Christos Papadimitriou, Effie Panayotopoulou and Maria Sotiropoulou and has published in prestigious journals such as Fertility and Sterility, Journal of Clinical Pathology and Breast Cancer Research and Treatment.

In The Last Decade

S. Markaki

44 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Markaki Greece 18 305 299 208 182 182 44 925
Mehran Ghaderi Sweden 23 219 0.7× 319 1.1× 111 0.5× 300 1.6× 143 0.8× 57 1.4k
James Scurry Australia 19 240 0.8× 358 1.2× 392 1.9× 82 0.5× 182 1.0× 54 1.2k
S A Cannistra United States 15 324 1.1× 405 1.4× 236 1.1× 107 0.6× 98 0.5× 24 1.1k
M. Ruhul Quddus United States 19 269 0.9× 176 0.6× 372 1.8× 88 0.5× 157 0.9× 102 1.1k
Dimosthenis Miliaras Greece 18 153 0.5× 187 0.6× 200 1.0× 50 0.3× 97 0.5× 68 763
Tjoung‐Won Park Germany 13 168 0.6× 222 0.7× 208 1.0× 59 0.3× 110 0.6× 21 719
Chih‐Ping Han Taiwan 15 199 0.7× 271 0.9× 117 0.6× 40 0.2× 123 0.7× 45 658
Fabio Cappuccini United States 17 300 1.0× 210 0.7× 271 1.3× 43 0.2× 70 0.4× 36 843
B. Frankendal Sweden 20 166 0.5× 140 0.5× 436 2.1× 61 0.3× 118 0.6× 50 998
Stuart C. Lauchlan United States 19 157 0.5× 235 0.8× 667 3.2× 139 0.8× 68 0.4× 36 1.2k

Countries citing papers authored by S. Markaki

Since Specialization
Citations

This map shows the geographic impact of S. Markaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Markaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Markaki more than expected).

Fields of papers citing papers by S. Markaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Markaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Markaki. The network helps show where S. Markaki may publish in the future.

Co-authorship network of co-authors of S. Markaki

This figure shows the co-authorship network connecting the top 25 collaborators of S. Markaki. A scholar is included among the top collaborators of S. Markaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Markaki. S. Markaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drosos, Yiannis, Eumorphia G. Konstantakou, S. Markaki, et al.. (2023). Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway. Cancers. 15(14). 3730–3730. 4 indexed citations
2.
Murray, Samuel, Helena Linardou, Giannis Mountzios, et al.. (2010). Low frequency of somatic mutations in uterine sarcomas: A molecular analysis and review of the literature. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 686(1-2). 68–73. 15 indexed citations
3.
Πρωτόπαπας, Αθανάσιος, S. Markaki, Dimitrios Milingos, et al.. (2010). Immunohistochemical expression of matrix metalloproteinases, their tissue inhibitors, and cathepsin-D in ovarian endometriosis: correlation with severity of disease. Fertility and Sterility. 94(6). 2470–2472. 5 indexed citations
4.
Markaki, S., Evangelos Lianos, Panagiotis Peitsidis, et al.. (2009). Clinicopathological features of primary fallopian tube carcinoma: a single institution experience.. PubMed. 30(4). 389–95. 4 indexed citations
5.
Πρωτόπαπας, Αθανάσιος, Spyros Milingos, S. Markaki, et al.. (2008). Cystic Uterine Tumors. Gynecologic and Obstetric Investigation. 65(4). 275–280. 22 indexed citations
6.
Milingos, Spyros, Αθανάσιος Πρωτόπαπας, Christos Papadimitriou, et al.. (2007). Laparoscopy in the evaluation of women with unexplained ascites: An invaluable diagnostic tool. Journal of Minimally Invasive Gynecology. 14(1). 43–48. 8 indexed citations
7.
Nakopoulou, Lydia, Eleni Mylona, Nikolaos Kavantzas, et al.. (2006). Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Modern Pathology. 19(4). 556–563. 56 indexed citations
8.
Thomakos, Nikolaos, et al.. (2006). A Rare Case of Rectovaginal Endometriosis with Lymph Node Involvement. Gynecologic and Obstetric Investigation. 62(1). 45–47. 24 indexed citations
9.
Pappa, Kalliopi I., S. Markaki, A. Kyroudi, et al.. (2005). Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status. Gynecologic Oncology. 100(3). 596–600. 52 indexed citations
10.
Nakopoulou, L., et al.. (2005). Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast Carcinoma. Pathobiology. 72(5). 241–249. 31 indexed citations
11.
Πρωτόπαπας, Αθανάσιος, E Diakomanolis, A. Bamias, et al.. (2004). The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapy.. PubMed. 25(2). 225–9. 17 indexed citations
12.
Markaki, S., Alexandros Rodolakis, Efstathios Kastritis, et al.. (2004). Clinicopathological features of ovarian carcinosarcomas: a single institution experience. Gynecologic Oncology. 96(1). 136–142. 30 indexed citations
13.
Markaki, S., et al.. (2004). Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study. Gynecologic Oncology. 96(3). 860–864. 7 indexed citations
14.
Sotiropoulou, Maria, et al.. (2004). Angiogenic properties of carcinoma in situ and microinvasive carcinoma of the uterine cervix.. PubMed. 25(2). 219–21. 8 indexed citations
15.
Papadimitriou, Christos, S. Markaki, G. Vlachos, et al.. (2004). Hormonal Therapy with Letrozole for Relapsed Epithelial Ovarian Cancer. Oncology. 66(2). 112–117. 101 indexed citations
16.
17.
Markaki, S., et al.. (1993). Autopsy findings in burn injuries.. PubMed. 41(1). 5–8. 8 indexed citations
18.
Zachariades, Nicholas, et al.. (1991). Phleboliths. A report of three unusual cases. British Journal of Oral and Maxillofacial Surgery. 29(2). 117–119. 19 indexed citations
19.
Markaki, S., et al.. (1991). Ag-NORs in giant cell tumor of bones: are they useful in the estimation of tumor's behavior?. PubMed. 39(1-2). 42–6. 3 indexed citations
20.
Markaki, S., et al.. (1987). Intestinal Spirochaetosis. Pathology - Research and Practice. 182(6). 780–782. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehran Ghaderi Breakdown of academic impact, for papers by James Scurry Breakdown of academic impact, for papers by S A Cannistra Breakdown of academic impact, for papers by M. Ruhul Quddus Breakdown of academic impact, for papers by Dimosthenis Miliaras Breakdown of academic impact, for papers by Tjoung‐Won Park Breakdown of academic impact, for papers by Chih‐Ping Han Breakdown of academic impact, for papers by Fabio Cappuccini Breakdown of academic impact, for papers by B. Frankendal Breakdown of academic impact, for papers by Stuart C. Lauchlan
Rankless by CCL
2026